<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04969380</url>
  </required_header>
  <id_info>
    <org_study_id>UCI IRB HS# 2019-5520</org_study_id>
    <nct_id>NCT04969380</nct_id>
  </id_info>
  <brief_title>SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow</brief_title>
  <official_title>Safety and Efficacy of Sofacia Treatment to Improve Facial Lines and Wrinkles, to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sofwave Medical LTD</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sofwave Medical LTD</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Open-label, non-randomized, prospective, multi-center, self-controlled clinical study with&#xD;
      masked evaluation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligible patients will receive 2 face and neck treatments (4-6 weeks ± 2 weeks apart) using&#xD;
      the SofWave System. Each investigational site would treat the full face and submental zones&#xD;
      including 1. The forehead and temples (left and right including the peri orbital zone) to&#xD;
      lift the eyebrows 2. The cheeks (left and right including perioral zone and nasolabial folds)&#xD;
      3. Submental and sides of the neck (left and right) to lift lax skin.&#xD;
&#xD;
      All patients will return to the clinic for two follow up visits: 1. 7 days (FU1) post the&#xD;
      first treatment (Tx.1). 2. 3 months ± 2 weeks post last treatment (FU2).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 27, 2020</start_date>
  <completion_date type="Anticipated">February 27, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 27, 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in lift of lax tissue</measure>
    <time_frame>3 and 6 months post last treatment</time_frame>
    <description>As assessed by independent masked evaluators. Quantitative image analysis to objectively measure change in lift of the eyebrow and submental and neck lax tissue would be conducted by comparing baseline images to those taken at each visit post FU1 (Pre Tx.2, FU2)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Skin Laxity</condition>
  <arm_group>
    <arm_group_label>face and/or neck and/or submental zones</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the full face and/or neck and/or submental zones including 1. -The forehead and temples (left and right including the peri orbital zone) to lift the eyebrows 2. The cheeks (left and right including perioral zone and nasolabial folds) 3. Submental and sides of the neck</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sofwave</intervention_name>
    <description>The Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues.</description>
    <arm_group_label>face and/or neck and/or submental zones</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Healthy female and male subjects between the ages 35-80.&#xD;
&#xD;
          2. Non-Smoker.&#xD;
&#xD;
          3. Fitzpatrick skin type I-VI.&#xD;
&#xD;
          4. Desire to lift lax skin in the neck and submental and/or to lift the brows.&#xD;
&#xD;
          5. Able and willing to comply with all visit, treatment and evaluation schedules and&#xD;
             requirements.&#xD;
&#xD;
          6. Able to understand and provide written Informed Consent&#xD;
&#xD;
          7. Women of child-bearing age are required to be using a reliable method of birth control&#xD;
             at least 3 months prior to study enrollment.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnant or planning to become pregnant, having given birth less than 3 months ago,&#xD;
             and/or breast feeding.&#xD;
&#xD;
          2. Presence of any active systemic or local infections.&#xD;
&#xD;
          3. Presence of active local skin disease that may alter wound healing.&#xD;
&#xD;
          4. Severe solar elastosis.&#xD;
&#xD;
          5. History of smoking in past 10 years.&#xD;
&#xD;
          6. History of chronic drug or alcohol abuse.&#xD;
&#xD;
          7. Excessive subcutaneous fat on the cheeks.&#xD;
&#xD;
          8. Significant scarring in the area to be treated.&#xD;
&#xD;
          9. Severe or cystic facial acne, acutance uses during past 6 months.&#xD;
&#xD;
         10. Presence of a metal stent or implant in the facial area (dental implants and/or braces&#xD;
             are not excluded).&#xD;
&#xD;
         11. Inability to understand the protocol or to give informed consent.&#xD;
&#xD;
         12. History of cosmetic treatments in the facial area to be treated, including facial&#xD;
             skin-tightening procedure within the 6 months ; injectable (Botox or fillers) of any&#xD;
             type within the 6 months; ablative or non-ablative resurfacing/rejuvenation laser&#xD;
             treatment or light treatment within the past 6 months, dermabrasion or deep facial&#xD;
             peels within the past 12 months; facelift, blepharoplasty, or brow lift (including&#xD;
             contour threads) within the past 12 months.&#xD;
&#xD;
         13. Taking Isotretinoin or other oral retinoid within the past 6 months; taking&#xD;
             anti-platelet or anti-coagulant within the past 2 weeks.&#xD;
&#xD;
         14. As per the investigator's discretion, any physical or mental condition which might&#xD;
             make it unsafe for the subject to participate in this study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ruthie Amir, MD</last_name>
    <role>Study Director</role>
    <affiliation>Sofwave</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ruthie Amir, MD</last_name>
    <phone>+972-4-6432994</phone>
    <email>ruthie@sofwave.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shlomit Mann, MSc</last_name>
    <phone>+972-4-6432994</phone>
    <email>shlomit@sofwave.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of California</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92697</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natasha Mesinkovska, MD, PhD</last_name>
      <phone>949-824-7103</phone>
      <email>dermresearch@uci.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 7, 2021</study_first_submitted>
  <study_first_submitted_qc>July 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 20, 2021</study_first_posted>
  <last_update_submitted>October 13, 2021</last_update_submitted>
  <last_update_submitted_qc>October 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Laxity Brow Lifting Skin Saggy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cutis Laxa</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

